武汉两家医院107例新型冠状病毒SARS-CoV-2感染出院患者的临床病程与结局
该回顾性病例系列纳入武汉大学中南医院和湖北浠水医院至2020年2月10日的107例COVID-19出院患者,收集流行病学、人口学和临床数据,比较存活者与死亡者的临床病程,分析死亡危险因素。结果显示病程呈三阶段:第1周以发热、咳嗽、呼吸困难、淋巴细胞减少和影像学多肺叶浸润为特征;第2周轻症开始缓解但淋巴细胞减少持续,重症出现白细胞增多、中性粒细胞增多和多器官功能恶化;第3周轻症临床缓解,重症持续淋巴细胞减少、严重急性呼吸窘迫综合征、难治性休克、无尿性急性肾损伤、凝血病、血小板减少和死亡。高龄和男性为不良结局的独立危险因素。
要点
- 发病后7–13天是COVID-19病程的关键阶段,重症在此期出现多器官功能恶化。
- 第1周特征为发热、咳嗽、呼吸困难、淋巴细胞减少及影像学多肺叶浸润。
- 第2周轻症发热咳嗽缓解、血小板升至正常,但淋巴细胞减少持续;重症出现白细胞增多、中性粒细胞增多和多器官功能障碍恶化。
- 第3周轻症除淋巴细胞减少外临床缓解;重症可出现严重急性呼吸窘迫综合征、难治性休克、无尿性急性肾损伤、凝血病、血小板减少和死亡。
- 高龄和男性是不良结局的独立危险因素。
适用人群与场景
- 武汉大学中南医院和湖北浠水医院至2020年2月10日的107例COVID-19出院患者。
红旗征与不能漏的情况
- 重症患者在第2周出现白细胞增多、中性粒细胞增多和多器官功能障碍恶化。
- 第3周重症患者出现持续淋巴细胞减少、严重急性呼吸窘迫综合征、难治性休克、无尿性急性肾损伤、凝血病、血小板减少和死亡。
研究设计与关键结果
- 回顾性病例系列纳入107例COVID-19出院患者,比较存活者与死亡者的临床病程并分析死亡危险因素。
- 病程呈三阶段:第1周以发热、咳嗽、呼吸困难、淋巴细胞减少和影像学多肺叶浸润为特征。
- 第2周轻症发热、咳嗽和全身症状开始缓解,血小板计数升至正常范围,但淋巴细胞减少持续;重症以白细胞增多、中性粒细胞增多和多器官功能障碍恶化为主要表现。
- 第3周轻症临床缓解(除淋巴细胞减少外);重症表现为持续淋巴细胞减少、严重急性呼吸窘迫综合征、难治性休克、无尿性急性肾损伤、凝血病、血小板减少和死亡。
- 高龄和男性是不良结局的独立危险因素。
证据类型、等级与局限
- 证据类型:回顾性病例系列。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为发病后7–13天是COVID-19病程的关键阶段,应关注此期重症患者的多器官功能恶化。
- 作者认为高龄和男性是不良结局的独立危险因素,提示对此类患者加强监测。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: In December 2019, coronavirus disease 2019 (COVID-19) outbreak was reported from Wuhan, China. Information on the clinical course and prognosis of COVID-19 was not thoroughly described. We described the clinical courses and prognosis in COVID-19 patients.
METHODS: Retrospective case series of COVID-19 patients from Zhongnan Hospital of Wuhan University in Wuhan and Xishui Hospital, Hubei Province, China, up to February 10, 2020. Epidemiological, demographic, and clinical data were collected. The clinical course of survivors and non-survivors were compared. Risk factors for death were analyzed.
RESULTS: A total of 107 discharged patients with COVID-19 were enrolled. The clinical course of COVID-19 presented as a tri-phasic pattern. Week 1 after illness onset was characterized by fever, cough, dyspnea, lymphopenia, and radiological multi-lobar pulmonary infiltrates. In severe cases, thrombocytopenia, acute kidney injury, acute myocardial injury, and adult respiratory distress syndrome were observed. During week 2, in mild cases, fever, cough, and systemic symptoms began to resolve and platelet count rose to normal range, but lymphopenia persisted. In severe cases, leukocytosis, neutrophilia, and deteriorating multi-organ dysfunction were dominant. By week 3, mild cases had clinically resolved except for lymphopenia. However, severe cases showed persistent lymphopenia, severe acute respiratory dyspnea syndrome, refractory shock, anuric acute kidney injury, coagulopathy, thrombocytopenia, and death. Older age and male sex were independent risk factors for poor outcome of the illness.
CONCLUSIONS: A period of 7-13 days after illness onset is the critical stage in the COVID-19 course. Age and male gender were independent risk factors for death of COVID-19.
参考来源
- Wang D, Yin Y, Hu C, et al. Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China. Crit Care. 2020. PMID: 32354360. doi:10.1186/s13054-020-02895-6
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。